Wall Street analysts forecast that Healthways, Inc. (NASDAQ:TVTY) will post $0.36 earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Five analysts have provided estimates for Healthways’ earnings. The lowest EPS estimate is $0.35 and the highest is $0.37. Healthways reported earnings of $0.30 per share during the same quarter last year, which would indicate a positive year-over-year growth rate of 20%. The business is scheduled to report its next quarterly earnings report on Tuesday, November 7th.
On average, analysts expect that Healthways will report full-year earnings of $1.53 per share for the current fiscal year, with EPS estimates ranging from $1.51 to $1.56. For the next fiscal year, analysts anticipate that the firm will post earnings of $1.66 per share, with EPS estimates ranging from $1.59 to $1.74. Zacks’ EPS calculations are a mean average based on a survey of sell-side analysts that follow Healthways.
Healthways (NASDAQ:TVTY) last announced its quarterly earnings data on Thursday, July 27th. The company reported $0.41 EPS for the quarter, topping the Zacks’ consensus estimate of $0.38 by $0.03. Healthways had a return on equity of 29.81% and a net margin of 17.30%. The firm had revenue of $138.90 million during the quarter, compared to analyst estimates of $138.15 million. The firm’s revenue was up 11.1% compared to the same quarter last year.
TVTY has been the subject of a number of research analyst reports. BidaskClub raised Healthways from a “buy” rating to a “strong-buy” rating in a research note on Friday, June 9th. ValuEngine raised Healthways from a “hold” rating to a “buy” rating in a research note on Friday, September 1st. UBS AG boosted their target price on Healthways from $37.00 to $43.00 and gave the company a “buy” rating in a research note on Friday, June 23rd. Barrington Research boosted their target price on Healthways from $35.00 to $44.00 and gave the company an “outperform” rating in a research note on Friday, July 28th. Finally, Cantor Fitzgerald boosted their target price on Healthways from $34.00 to $42.00 and gave the company an “overweight” rating in a research note on Friday, June 9th. Two research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. Healthways has a consensus rating of “Buy” and an average target price of $39.88.
In other news, insider Mary Flipse sold 1,340 shares of the company’s stock in a transaction dated Friday, August 11th. The stock was sold at an average price of $37.32, for a total transaction of $50,008.80. Following the completion of the transaction, the insider now directly owns 75,187 shares of the company’s stock, valued at $2,805,978.84. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Glenn Hargreaves sold 21,105 shares of the company’s stock in a transaction dated Friday, August 4th. The stock was sold at an average price of $38.00, for a total value of $801,990.00. Following the transaction, the insider now directly owns 59,077 shares of the company’s stock, valued at $2,244,926. The disclosure for this sale can be found here. Insiders have sold 1,809,913 shares of company stock valued at $68,582,025 over the last ninety days. 8.42% of the stock is owned by insiders.
Several hedge funds have recently bought and sold shares of TVTY. Vanguard Group Inc. acquired a new position in shares of Healthways during the first quarter worth about $135,544,000. BlackRock Inc. acquired a new position in shares of Healthways during the first quarter worth about $123,015,000. North Tide Capital LLC acquired a new position in shares of Healthways during the first quarter worth about $72,750,000. Dimensional Fund Advisors LP acquired a new position in shares of Healthways during the first quarter worth about $70,660,000. Finally, JPMorgan Chase & Co. acquired a new position in shares of Healthways during the first quarter worth about $34,618,000.
Shares of Healthways (NASDAQ TVTY) opened at 38.60 on Friday. The firm’s 50-day moving average price is $38.03 and its 200-day moving average price is $34.53. Healthways has a 12 month low of $19.25 and a 12 month high of $41.55. The firm has a market capitalization of $1.52 billion, a price-to-earnings ratio of 17.39 and a beta of 0.41.
Healthways Company Profile
Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Healthways Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthways Inc. and related companies with MarketBeat.com's FREE daily email newsletter.